Circulating anandamide and blood pressure in patients with obstructive sleep apnea

Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective

(2017) Erna S. Arnardottir et al.   SLEEP

Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity

(2010) G. S. Gilmartin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance

(2010) Carmelo Quarta et al.   Cell Metabolism

Interactions Between Obesity and Obstructive Sleep Apnea

(2010) Abel Romero-Corral et al.   CHEST

Circulating Endocannabinoids and N-acyl-ethanolamides in Patients with Sleep Apnea – Specific Role of Oleoylethanolamide

(2010) R. Jumpertz et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

(2010) Joseph Tam et al.   JOURNAL OF CLINICAL INVESTIGATION

Circulating endocannabinoid concentrations during orthostatic stress

(2009) Christoph Schroeder et al.   CLINICAL AUTONOMIC RESEARCH

Obstructive sleep apnea and cardiovascular disease

(2009) Andrew D Calvin et al.   CURRENT OPINION IN CARDIOLOGY

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects

(2009) Vincenzo Di Marzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results

(2009) Luis M Ruilope et al.   JOURNAL OF HYPERTENSION

Modulation of the Endocannabinoid System in Cardiovascular Disease

(2008) Pál Pacher et al.   HYPERTENSION